About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« AstraZeneca Stops Buying Its Own Stock | Main | The Return of CB1 »

October 3, 2012

November Conference on Drug Discovery in Boston

Email This Entry

Posted by Derek

I wanted to take a moment to mention this conference, coming up on November 6 at Northeastern in Boston. They have a wide-ranging program on drug discovery scheduled, with some people that I know from experience to be good speakers. Worth a look if you're in the area.

Comments (24) + TrackBacks (0) | Category: Chemical News


1. The Sanity Inspector on October 3, 2012 1:29 PM writes...

Dr. Lowe, if you have any pull with the Corante webmasters, I wish they would give the website a thorough going-over. There's so much deadwood that, from the front page at least, it's hard to find any new content. I enjoyed the site a lot in the mid-Aughties, and I hate to see it turn into a mostly-dead pundit ranch.

Permalink to Comment

2. MoMo on October 3, 2012 2:09 PM writes...

@1 I agree, other than Ol' Whitesides, who has done more chemistry than God, the rest are errand boys, sent by grocery clerks, to collect the bills.

Permalink to Comment

3. Sili on October 3, 2012 2:45 PM writes...

Funny, my suggestion would be Derek to move to another host.

I'm afraid I don't now how well Scienceblogs pays after the National Geographic takeover.

Permalink to Comment

4. Lyle Langley on October 3, 2012 2:51 PM writes...

Nothing like a good old conference about Drug Discovery with speakers that have little experience doing so. Did your company compel you to mention this conference? Don't know that I've seen a bigger "yawner" of a conference.

Permalink to Comment

5. MooMoo on October 3, 2012 3:37 PM writes...

MoMo; I bet those errand boys have published more significant work than you ever will. If they are errand boys, I guess that makes you a chimney sweep at best.

Permalink to Comment

6. drug_hunter on October 3, 2012 5:29 PM writes...

I'll be there at least! I think I will learn a lot from all these speakers.

Thanks for the heads up Derek.

Permalink to Comment

7. Dr. Zoidberg on October 4, 2012 8:23 AM writes...

Thanks for the heads-up Derek.

Permalink to Comment

8. MoMo on October 4, 2012 12:18 PM writes...

Say what you will MooMoo in this cyberspace.

Other than Whitesides how many drugs have these lecturers had go to Phase I, or further or companies brought to IPO? This should be the metric here- not how many publications.

Publications do not meet shit in drug discovery and you know that, so what is the attraction here?

A bunch of scientists playing drug discoverers.

Now give me a Julian Adams lecture series anyday. Here is a guy who knows how to discover drugs, has done it, and knows what kind of assholes populate the drug discovery landscape- and is not a poseur and is in Boston.

where is he on the agenda?

Permalink to Comment

9. newnickname on October 4, 2012 12:30 PM writes...

@8: "Other than Whitesides how many drugs have these lecturers had go to Phase I, or further or companies brought to IPO?"

Leroy Hood invented (or contributed to the commercialization of) the DNA sequencer, protein synthesizer, DNA synthesizer, etc.. "He has founded or co-founded more than 10 companies, including Applied Biosystems and Amgen, that commercialize technologies."

Permalink to Comment

10. MooMoo on October 4, 2012 12:41 PM writes...

MoMo, again, your condescending piffle speaks only to your own woeful ignorance. Among other things, Hood pioneered the DNA sequencer, Arun Ghosh invented darunavir, Eric Olson led the development of Vertex's CF drug and Jay Bradner was recently profiled in Science for his work on epigenetic drugs. And you must not have the faintest idea about drug discovery if you think that publications contribute nothing to the fundamentals of the science.

Permalink to Comment

11. Cellbio on October 4, 2012 3:24 PM writes...

Wasn't it Hunkapiller who was really behind everything Applied Biosystems? And Hood had virtually nothing to do with Amgen's success. Just saying. He is a visionary, very successful, but gets more credit than he deserves.

Permalink to Comment

12. Anonymous on October 4, 2012 3:37 PM writes...

MooMoo - Darunavir was first exemplified in a Searle patent (US6046190A Table 16K). Arun Ghosh is not listed as an inventor as he did not work there.

Permalink to Comment

13. MoMo on October 4, 2012 5:43 PM writes...

Condescending piffle? There is nothing condescending about anything I have stated.

But keep up the hero-worship and go "learn" something.

This is America and how you spend your time instead of really working is up to you.

Now get back to the lab and create something!

Not just co-opt it!

Permalink to Comment

14. MooMoo on October 4, 2012 8:27 PM writes...

"This is America and how you spend your time instead of really working is up to you"

Case in point: MoMo, who spends all his/her time here broadcasting sanctimonious condescension instead of "getting into the lab and creating something". How about you try to accomplish a tenth of what these guys have accomplished? I thought not...

Permalink to Comment

15. Anon on October 4, 2012 9:14 PM writes...

Nice hypocrisy #14!

Permalink to Comment

16. drug_hunter on October 4, 2012 9:50 PM writes...

I'm still going... guess I have more to learn than some other folks.

Permalink to Comment

17. Jay Bradner on October 4, 2012 10:08 PM writes...

Thanks Derek. Was excited to be invited and also looking forward to the day. MoMo please let me know what I should do with your dry cleaning. Best. Jay

Permalink to Comment

18. Sebastian on October 5, 2012 1:39 AM writes...

Fine trolling sir, fine trolling indeed

Permalink to Comment

19. KtheKnight on October 5, 2012 4:57 AM writes...

Hi MoMo
Just read wikipedia for your ignorance:
Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006.
And during his time at Merck Arun introduced chiral aminoindanol into drug discovery, just search the papers which using this chiral intermediate in drug or chiral synthesis.

Permalink to Comment

20. MooMoo on October 5, 2012 10:23 AM writes...

#15: Unlike MoMo this is the first time I have commented on the blog. I rest my case.

Permalink to Comment

21. MoMo on October 5, 2012 11:21 AM writes...


OK you win the Dominance Competition! Good Boy, Here's a Treat for You!

Now get back to work

Permalink to Comment

22. MooMoo on October 8, 2012 9:05 AM writes...

#21: I rest my case again.

Permalink to Comment

23. MoMo on October 16, 2012 9:13 AM writes...

MooMoo and Jay Bradner,

Meet me at the next ACS meeting at their booth when the expo opens.

We can all have a good laugh!

Now sharpen those pencils for Big Meeting!

Its time to learn something!

Permalink to Comment

24. MooMoo on November 1, 2012 4:03 PM writes...

23: Instead, why don't you show up at this conference and tell all the participants that their work doesn't mean squat?

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry